June 29th 2023
Routine surface wipe testing helps identify specific areas of hazardous drug contamination and guide nurse leaders towards establishing improved protocols.
Clinical ConsultationsTM: Focusing on Fabry Disease in Females: Individualizing Diagnostic and Counseling Plans to Improve Long-Term Outcomes
View More
2022 Annual Psychiatric Times™ World CME Conference™ - Day One
View More
Expert Illustrations & Commentaries™: Exploring the Clinical Rationale for Antagonizing Inflammatory IL-1-beta Signaling in NSCLC
View More
2022 Annual Psychiatric Times™ World CME Conference™ - Day Two
View More
2022 Annual Psychiatric Times™ World CME Conference™ - Day Three
View More
Advances In™: Meeting Unmet Clinical Needs in AML with Evolving Therapeutic Approaches
View More
Bridging the Care Gap in Anemia in CKD: A Comprehensive Guide to Enhancing Patient Care
Register Now!
Community Practice Connections™: Chronic Fibrosing ILDs With Progressive Phenotype–Are You Aware of the Latest Data on Diagnosis and Emerging Treatments?
View More
Catching Them Early: A Real-World Case Discussion on the Application of Testing Methodologies to Identify Key Markers Across NSCLC
View More
Shaping the Management of Multiple Sclerosis – The Potential for BTK Inhibitors in Clinical Practice
View More
Anemia of Chronic Kidney Disease: Improving Recognition and Early Treatment in the Primary Care Setting
View More
Transforming Multiple Sclerosis Care – Clinical Updates on the Effects of BTK Inhibitors
10/13/2023
Register Now!
20th Annual Meeting of the International Society of Gastrointestinal Oncology®
Register Now!
Advances In™ Pediatric Neuroblastoma: Exploring Current and Emerging Therapeutic Approaches for Relapsed/Refractory Disease and CNS Metastases
View More
Clinical Consultations: Individualizing Management of Uveitic Macular Edema - Clinical Updates in Treatment Options
View More
From Clinical Trials to Clinical Practice – Incorporating Screening and Assessment Strategies for the Early Diagnosis of Alzheimer Disease
View More
Taking Pompe Disease Management to the Next Level: Optimizing Clinical Assessments and Treatment Decision-Making
View More
Evaluating the Evolution of CKD Treatment: What’s New and How Can We Incorporate It?
View More
2nd Annual International Congress on Pediatric Oncology
View More
2022 BURST Year in Review™: Reflecting on Recent Evidence for Testing in Patients with GI Cancers
View More
2022 BURST Year in Review™: How Has Recent Evidence in Testing Elevated Outcomes in Patients with Lung Cancers
View More
4th Annual Virtual Tumor Board®: Diagnosis and Management of Polycythemia Vera and Myelofibrosis
View More
Medical Crossfire®: Experts Address Your Burning Questions on the Evolving Treatment of MF, PV, and ET!
View More
Community Practice Connections™: 23rd Annual International Lung Cancer Congress®
View More
Burst CME: Selecting an Appropriate Influenza Vaccine for Adults 65 Years and Older
View More
Expanding Options Beyond Conventional Therapy in HR+ Breast Cancer to Overcome Unmet Needs
View More
Virtual Testing Board: Digging Deeper on Your Testing Reports to Elevate Patient Outcomes in Advanced Non–Small Cell Lung Cancer
View More
Best Practice in the Multidisciplinary Care of the Patient with HS
View More
Addressing Challenges in the Management of HS in Special Populations
View More
Community Practice Connections™: Ophthalmology and Oncology Perspectives on Integrating Novel Bispecific Antibodies Into the Uveal Melanoma Treatment Paradigm
View More
Opinion: The Good Nurse Brings Safe Narcotic Handling to the Forefront of Nursing Minds
December 6th 2022Sometimes nurses inappropriately handle high-risk medications. It is important that other nurses, especially those who work in pain management, hold colleagues accountable to promote patient safety.
Fast Facts for the Front Line: Central Line-Associated Bloodstream Infection
August 2nd 2017Preventing central line–associated bloodstream infections is a top priority for healthcare practitioners, and following basic safety protocols, such as handwashing and line flushing, is essential to the effort.
Crafting a Harmonized Approach to Safety
October 26th 2015In her role as division head of Occupational & Environmental Medicine at the University of Maryland, Melissa A. McDiarmid, MD, MPH, spends a lot of her time working with individuals who have been occupationally or environmentally exposed to toxic substances..
As Clinics Await USP 800, Focus Must Remain on Collaboration and Awareness at All Levels
September 16th 2015As the new USP Chapter 800 regulations for the handling of hazardous drugs are being finalized, stakeholders-including oncology nurses-are preparing for a renewed emphasis on the safe preparation and administration of chemotherapy in their daily practice.
Professional Groups Unite to Make Safe Chemo Handling a Priority in Practice
March 24th 2015Big changes are ahead for oncology nurses and other healthcare professionals who prepare and administer hazardous drugs, as new regulations for safe handling are being finalized by the US Pharmacopeial Convention (USP).
Best Practice in Chemotherapy Handling Means Multiple Layers of Precaution
November 18th 2014Several of the nation's leading oncology nurse advocates for raising awareness of the importance of safe handling of chemotherapy drugs gathered recently to discuss some of the current challenges they face in their practices, along with risk reduction strategies that, if adopted, would benefit nurses nationwide.
Multimillion Dollar Research Program Will Study Oncology Nurse Exposure to Hazardous Drugs
September 9th 2014Underscoring the need to raise awareness among oncology nurses of the importance of adhering to safety precautions when administering chemotherapy and other hazardous drugs, the NIOSH has awarded a $2.3 million research grant to identify exposure risks and promote strategies to combat them.
Promoting a Culture of Safe Handling
April 29th 2014April is National Safe Handling Awareness Month, a great time to spotlight the ongoing importance of implementing safe practices when handling chemotherapy and other hazardous drugs in the oncology setting-not only for healthcare practitioners, but for patients and their caregivers, too.